MedTrace Logo

Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia

NCT04248010 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-04-05

No results posted yet for this study

Summary

This project compares standard tDCS to individualized high-definition tDCS (HD-tDCS) for treatment of auditory verbal hallucinations in schizophrenia.

Conditions

  • Schizophrenia and Related Disorders

Interventions

DEVICE

neuroConn DC-Stimulator MR

standard tDCS, active \& sham

DEVICE

Soterix MxN HD-tES

HD-tDCS, active \& sham

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2025-06-01
Completion
2025-06-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248010 on ClinicalTrials.gov